Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.1 SEK | +2.31% | +1.64% | +8.77% |
May. 07 | Medivir Aktiebolag Approves Board Appointments | CI |
Apr. 30 | Transcript : Medivir AB, Q1 2024 Earnings Call, Apr 30, 2024 |
Sales 2024 * | 32.3M 2.98M | Sales 2025 * | 52.05M 4.8M | Capitalization | 347M 32.03M |
---|---|---|---|---|---|
Net income 2024 * | -75M -6.92M | Net income 2025 * | -92M -8.49M | EV / Sales 2024 * | 5.65 x |
Net cash position 2024 * | 165M 15.19M | Net cash position 2025 * | 245M 22.6M | EV / Sales 2025 * | 1.97 x |
P/E ratio 2024 * |
-5.64
x | P/E ratio 2025 * |
-2.45
x | Employees | 10 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 64.1% |
Latest transcript on Medivir AB
1 day | +2.31% | ||
1 week | +1.64% | ||
Current month | -1.59% | ||
1 month | +17.42% | ||
3 months | +1.66% | ||
6 months | -15.08% | ||
Current year | +8.77% |
Managers | Title | Age | Since |
---|---|---|---|
Jens Lindberg
CEO | Chief Executive Officer | 53 | 22-01-23 |
Director of Finance/CFO | 50 | 19-08-11 | |
Uli Alf Hacksell
CHM | Chairman | 74 | 18-05-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Uli Alf Hacksell
CHM | Chairman | 74 | 18-05-02 |
Director/Board Member | 68 | 18-05-02 | |
Yilmaz Mahshid
BRD | Director/Board Member | 45 | 20-05-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 3.1 | +2.31% | 117,514 |
24-05-08 | 3.03 | +1.00% | 38,739 |
24-05-07 | 3 | -4.15% | 91,682 |
24-05-06 | 3.13 | +2.62% | 53,014 |
24-05-03 | 3.05 | -3.79% | 580,373 |
Delayed Quote Nasdaq Stockholm, May 10, 2024 at 11:29 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.77% | 32.05M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- MVIR B Stock